104 related articles for article (PubMed ID: 9075174)
1. Vocal fundamental frequency measures as a reflection of tumor response to chemotherapy in patients with advanced laryngeal cancer.
Orlikoff RF; Kraus DH; Harrison LB; Ho ML; Gartner CJ
J Voice; 1997 Mar; 11(1):33-9. PubMed ID: 9075174
[TBL] [Abstract][Full Text] [Related]
2. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience.
Shirinian MH; Weber RS; Lippman SM; Dimery IW; Earley CL; Garden AS; Michaelson J; Morrison WH; Kramer A; Byers R
Head Neck; 1994; 16(1):39-44. PubMed ID: 7510276
[TBL] [Abstract][Full Text] [Related]
3. Assessing vocal function after chemoradiation for advanced laryngeal carcinoma.
Woodson GE; Rosen CA; Murry T; Madasu R; Wong F; Hengesteg A; Robbins KT
Arch Otolaryngol Head Neck Surg; 1996 Aug; 122(8):858-64. PubMed ID: 8703390
[TBL] [Abstract][Full Text] [Related]
4. Does vocal cord fixation preclude nonsurgical management of laryngeal cancer?
Solares CA; Wood B; Rodriguez CP; Lorenz RR; Scharpf J; Saxton J; Rybicki LA; Strome M; Esclamado R; Lavertu P; Adelstein DJ
Laryngoscope; 2009 Jun; 119(6):1130-4. PubMed ID: 19358250
[TBL] [Abstract][Full Text] [Related]
5. A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients.
Dyckhoff G; Plinkert PK; Ramroth H
BMC Cancer; 2017 Sep; 17(1):609. PubMed ID: 28863776
[TBL] [Abstract][Full Text] [Related]
6. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer.
Eisbruch A; Thornton AF; Urba S; Esclamado RM; Carroll WR; Bradford CR; Hazuka MB; Littles FJ; Strawderman M; Wolf GT
J Clin Oncol; 1996 Aug; 14(8):2322-30. PubMed ID: 8708724
[TBL] [Abstract][Full Text] [Related]
8. Oncologic and Functional Outcomes of Surgical and Nonsurgical Treatment of Advanced Squamous Cell Carcinoma of the Supraglottic Larynx.
Elegbede AI; Rybicki LA; Adelstein DJ; Kaltenbach JA; Lorenz RR; Scharpf J; Burkey BB
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1111-7. PubMed ID: 25950990
[TBL] [Abstract][Full Text] [Related]
9. [The results and toxicity of organ preservation treatment for locoregionally advanced laryngeal and hypopharyngeal cancer].
Kiprian D; Kawecki A; Jarząbski A; Michalski W; Pawłowska-Sendułka B
Otolaryngol Pol; 2011; 65(5):363-8. PubMed ID: 22078287
[TBL] [Abstract][Full Text] [Related]
10. Treatment results of alternating chemoradiotherapy with early assessment for advanced laryngeal cancer: A multi-institutional phase II study.
Nakata Y; Ijichi K; Hanai N; Nishikawa D; Suzuki H; Hirakawa H; Kodaira T; Fujimoto Y; Fujii T; Miyazaki T; Shimizu T; Hasegawa Y
Auris Nasus Larynx; 2017 Feb; 44(1):104-110. PubMed ID: 27435048
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of Acoustic Analysis Measurements in the Evaluation of Patients With Different Laryngeal Diagnoses.
Lopes LW; Batista Simões L; Delfino da Silva J; da Silva Evangelista D; da Nóbrega E Ugulino AC; Oliveira Costa Silva P; Jefferson Dias Vieira V
J Voice; 2017 May; 31(3):382.e15-382.e26. PubMed ID: 27742492
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography evaluation after induction chemotherapy for T3 laryngeal cancer: Does response correlate with vocal cord mobility?
Garcia GCTE; Gorphe P; Hartl D; Ammari S; Even C; Tao Y; Balleyguier C; Varoquaux A; Bidault F
Oral Oncol; 2019 Mar; 90():13-16. PubMed ID: 30846170
[TBL] [Abstract][Full Text] [Related]
13. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma.
Teknos TN; Cox C; Barrios MA; Chepeha DB; Bradford CR; Fisher SG; Wolf GT
Laryngoscope; 2002 May; 112(5):844-51. PubMed ID: 12150616
[TBL] [Abstract][Full Text] [Related]
14. [Induction chemotherapy and larynx preservation: is such practice useful?].
Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
[TBL] [Abstract][Full Text] [Related]
15. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
16. Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma.
Bradford CR; Wolf GT; Carey TE; Zhu S; Beals TF; Truelson JM; McClatchey KD; Fisher SG
Otolaryngol Head Neck Surg; 1999 Nov; 121(5):534-8. PubMed ID: 10547465
[TBL] [Abstract][Full Text] [Related]
17. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer.
Pfister DG; Strong E; Harrison L; Haines IE; Pfister DA; Sessions R; Spiro R; Shah J; Gerold F; McLure T
J Clin Oncol; 1991 May; 9(5):850-9. PubMed ID: 2016629
[TBL] [Abstract][Full Text] [Related]
18. Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial).
Dietz A; Rudat V; Dreyhaupt J; Pritsch M; Hoppe F; Hagen R; Pfreundner L; Schröder U; Eckel H; Hess M; Schröder M; Schneider P; Jens B; Zenner HP; Werner JA; Engenhardt-Cabillic R; Vanselow B; Plinkert P; Niewald M; Kuhnt T; Budach W; Flentje M
Eur Arch Otorhinolaryngol; 2009 Aug; 266(8):1291-300. PubMed ID: 18972123
[TBL] [Abstract][Full Text] [Related]
19. Vocal function following radiation for non-laryngeal versus laryngeal tumors of the head and neck.
Fung K; Yoo J; Leeper HA; Hawkins S; Heeneman H; Doyle PC; Venkatesan VM
Laryngoscope; 2001 Nov; 111(11 Pt 1):1920-4. PubMed ID: 11801970
[TBL] [Abstract][Full Text] [Related]
20. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
Altundag O; Gullu I; Altundag K; Yalcin S; Ozyar E; Cengiz M; Akyol F; Yucel T; Hosal S; Sozeri B
Head Neck; 2005 Jan; 27(1):15-21. PubMed ID: 15515158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
